Change search
ReferencesLink to record
Permanent link

Direct link
A STAT4 risk allele is associated with ischemic cerebrovascular events and antiphospholipid antibodies in Systemic Lupus Erythematosus.
Show others and affiliations
2009 (English)In: Annals of the Rheumatic Diseases, ISSN 0003-4967, E-ISSN 1468-2060Article in journal (Refereed) Published
Abstract [en]

OBJECTIVE: To investigate if the risk allele for systemic lupus erythematosus (SLE) in the signal transducer and activator of transcription factor 4 (STAT4) gene, defined by the single nucleotide polymorphism (SNP) rs10181656(G), is associated with vascular events and/or presence of pro-thrombotic antiphospholipid antibodies (aPL) in SLE patients. METHODS: We genotyped two independent groups of unrelated SLE patients of Swedish ethnicity (n=424 and 154) and tabulated occurrence of previous manifestations of ischemic heart disease (IHD), ischemic cerebrovascular disease (ICVD) and venous thromboembolic events (VTE). aPL were measured with ELISA. Matched controls (n=492 and 194) were genotyped. RESULTS: The STAT4 risk allele was more frequent in SLE patients with previous arterial events [combined odds ratio (OR(c))=1.5, 95% confidence interval (CI) 1.1-2.0] compared to patients without such events. The association was mainly attributable to an accumulation of the risk allele among patients with ICVD (OR(c)=2.3, CI 1.6-3.3). There was no association with IHD or VTE. The presence of two or more aPLs was associated with the risk allele (OR(c)=1.6, CI 1.2-2.0). In multivariable-adjusted logistic regression analyses treatment for hypertension, at least one STAT4 risk allele, older age, IgG anticardiolipin antibodies and longer SLE duration remained independently associated with previous ICVD (p</=0.02 for all). CONCLUSION: SLE patients with the STAT4 risk allele had a strikingly increased risk of ICVD, comparable in magnitude to that of hypertension. Our results imply that a genetic predisposition is an important and previously unrecognized risk factor for ICVD in SLE, and that aPLs may be one underlying mechanism.

Place, publisher, year, edition, pages
National Category
Medical and Health Sciences
URN: urn:nbn:se:umu:diva-32404DOI: 10.1136/ard.2009.115535PubMedID: 19762360OAI: diva2:303092
Epub ahead of printAvailable from: 2010-03-11 Created: 2010-03-11 Last updated: 2010-04-10Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full textPubMed

Search in DiVA

By author/editor
Rantapää-Dahlqvist, Solbritt
By organisation
In the same journal
Annals of the Rheumatic Diseases
Medical and Health Sciences

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 25 hits
ReferencesLink to record
Permanent link

Direct link